• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚人群中巴雷特食管风险预测模型的验证

Validation of a risk prediction model for Barrett's esophagus in an Australian population.

作者信息

Ireland Colin J, Gordon Andrea L, Thompson Sarah K, Watson David I, Whiteman David C, Reed Richard L, Esterman Adrian

机构信息

School of Nursing and Midwifery, Division of Health Sciences, University of South Australia, Adelaide, SA, Australia.

School of Pharmacy and Medical Science, Division of Health Sciences, University of South Australia, Adelaide, SA, Australia.

出版信息

Clin Exp Gastroenterol. 2018 Mar 28;11:135-142. doi: 10.2147/CEG.S158627. eCollection 2018.

DOI:10.2147/CEG.S158627
PMID:29628770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5878665/
Abstract

BACKGROUND

Esophageal adenocarcinoma is a disease that has a high mortality rate, the only known precursor being Barrett's esophagus (BE). While screening for BE is not cost-effective at the population level, targeted screening might be beneficial. We have developed a risk prediction model to identify people with BE, and here we present the external validation of this model.

MATERIALS AND METHODS

A cohort study was undertaken to validate a risk prediction model for BE. Individuals with endoscopy and histopathology proven BE completed a questionnaire containing variables previously identified as risk factors for this condition. Their responses were combined with data from a population sample for analysis. Risk scores were derived for each participant. Overall performance of the risk prediction model in terms of calibration and discrimination was assessed.

RESULTS

Scores from 95 individuals with BE and 636 individuals from the general population were analyzed. The Brier score was 0.118, suggesting reasonable overall performance. The area under the receiver operating characteristic was 0.83 (95% CI 0.78-0.87). The Hosmer-Lemeshow statistic was =0.14. Minimizing false positives and false negatives, the model achieved a sensitivity of 74% and a specificity of 73%.

CONCLUSION

This study has validated a risk prediction model for BE that has a higher sensitivity than previous models.

摘要

背景

食管腺癌是一种死亡率很高的疾病,唯一已知的前驱病变是巴雷特食管(BE)。虽然在人群层面筛查BE不具有成本效益,但针对性筛查可能有益。我们开发了一种风险预测模型来识别患有BE的人群,在此我们展示该模型的外部验证情况。

材料与方法

开展一项队列研究以验证BE的风险预测模型。经内镜检查和组织病理学证实患有BE的个体完成了一份包含先前确定为此病风险因素的变量的问卷。他们的回答与来自人群样本的数据相结合进行分析。为每位参与者得出风险评分。评估了风险预测模型在校准和区分度方面的总体表现。

结果

分析了95例患有BE的个体和636例普通人群个体的评分。Brier评分为0.118,表明总体表现合理。受试者工作特征曲线下面积为0.83(95%置信区间0.78 - 0.87)。Hosmer-Lemeshow统计量为 =0.14。在尽量减少假阳性和假阴性的情况下,该模型的灵敏度为74%,特异度为73%。

结论

本研究验证了一种用于BE的风险预测模型,该模型比先前的模型具有更高的灵敏度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d31/5878665/9f713f264edc/ceg-11-135Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d31/5878665/b264e279b227/ceg-11-135Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d31/5878665/9f713f264edc/ceg-11-135Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d31/5878665/b264e279b227/ceg-11-135Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d31/5878665/9f713f264edc/ceg-11-135Fig2.jpg

相似文献

1
Validation of a risk prediction model for Barrett's esophagus in an Australian population.澳大利亚人群中巴雷特食管风险预测模型的验证
Clin Exp Gastroenterol. 2018 Mar 28;11:135-142. doi: 10.2147/CEG.S158627. eCollection 2018.
2
Development of a risk prediction model for Barrett's esophagus in an Australian population.澳大利亚人群中 Barrett 食管风险预测模型的开发。
Dis Esophagus. 2017 Nov 1;30(11):1-8. doi: 10.1093/dote/dox033.
3
Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study. Barrett 食管风险预测模型具有良好的区分能力,并在外部验证研究中具有可推广性。
Dig Dis Sci. 2020 Oct;65(10):2992-2999. doi: 10.1007/s10620-019-06018-2. Epub 2020 Jan 2.
4
Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score).预测 Barrett 食管的进展:Barrett 食管风险评分(BEAR 评分)的制定和验证。
Ann Surg. 2018 Apr;267(4):716-720. doi: 10.1097/SLA.0000000000002179.
5
MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.巴雷特食管和食管腺癌的微小RNA谱:腺性非天然上皮的差异
Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):429-37. doi: 10.1158/1055-9965.EPI-15-0161. Epub 2015 Nov 24.
6
Urinary metabolomic signature of esophageal cancer and Barrett's esophagus.食管癌和巴雷特食管的尿代谢组学特征。
World J Surg Oncol. 2012 Dec 15;10:271. doi: 10.1186/1477-7819-10-271.
7
Recent Advances in Screening for Barrett's Esophagus.巴雷特食管筛查的最新进展
Curr Treat Options Gastroenterol. 2018 Mar;16(1):1-14. doi: 10.1007/s11938-018-0166-2.
8
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.利用表观遗传学和临床特征预测巴雷特食管进展的三层风险分层模型。
PLoS One. 2008 Apr 2;3(4):e1890. doi: 10.1371/journal.pone.0001890.
9
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
10
Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.发展和验证一个模型以确定 Barrett 食管进展为肿瘤的风险。
Gastroenterology. 2018 Apr;154(5):1282-1289.e2. doi: 10.1053/j.gastro.2017.12.009. Epub 2017 Dec 19.

引用本文的文献

1
Cost-effective identification of Barrett's esophagus in the community: A first step towards screening.社区中具有成本效益的巴雷特食管识别:迈向筛查的第一步。
J Gastroenterol Hepatol. 2024 Dec;39(12):2654-2663. doi: 10.1111/jgh.16762. Epub 2024 Oct 10.
2
Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach.开发和验证一种用于诊断巴雷特食管的风险预测模型 (MARK-BE):一种病例对照机器学习方法。
Lancet Digit Health. 2020 Jan 1;2(1):E37-E48. doi: 10.1016/S2589-7500(19)30216-X. Epub 2019 Dec 5.

本文引用的文献

1
Development of a risk prediction model for Barrett's esophagus in an Australian population.澳大利亚人群中 Barrett 食管风险预测模型的开发。
Dis Esophagus. 2017 Nov 1;30(11):1-8. doi: 10.1093/dote/dox033.
2
External Validation of the Michigan Barrett's Esophagus Prediction Tool.密歇根巴雷特食管预测工具的外部验证
Clin Gastroenterol Hepatol. 2017 Jul;15(7):1124-1126. doi: 10.1016/j.cgh.2017.03.004. Epub 2017 Mar 11.
3
Past, present and future of Barrett's oesophagus.巴雷特食管的过去、现在与未来
Eur J Surg Oncol. 2017 Jul;43(7):1148-1160. doi: 10.1016/j.ejso.2017.02.004. Epub 2017 Feb 16.
4
Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overview.巴雷特食管向食管腺癌的进展:综述
Ann Gastroenterol. 2017;30(1):1-6. doi: 10.20524/aog.2016.0091. Epub 2016 Sep 30.
5
Sample size considerations for the external validation of a multivariable prognostic model: a resampling study.多变量预后模型外部验证的样本量考量:一项重抽样研究
Stat Med. 2016 Jan 30;35(2):214-26. doi: 10.1002/sim.6787. Epub 2015 Nov 9.
6
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.美国胃肠病学会临床指南:巴雷特食管的诊断与管理
Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51. doi: 10.1038/ajg.2015.322. Epub 2015 Nov 3.
7
Precision prevention of oesophageal adenocarcinoma.食管腺癌的精准预防
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):243-8. doi: 10.1038/nrgastro.2015.24. Epub 2015 Feb 10.
8
Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.澳大利亚巴雷特食管和早期食管腺癌诊断与管理临床实践指南。
J Gastroenterol Hepatol. 2015 May;30(5):804-20. doi: 10.1111/jgh.12913.
9
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.透明报告个体预后或诊断的多变量预测模型(TRIPOD):TRIPOD 声明。
Ann Intern Med. 2015 Jan 6;162(1):55-63. doi: 10.7326/M14-0697.
10
Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus.胃食管反流病症状及人口统计学因素作为巴雷特食管的预筛查工具
PLoS One. 2014 Apr 15;9(4):e94163. doi: 10.1371/journal.pone.0094163. eCollection 2014.